The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparing the clinical impact of pancreatic cyst surveillance programs: A trial of the ECOG-ACRIN cancer research group (EA2185).
 
David Weinberg
Research Funding - Fujifilm; Janssen
 
Jon Steingrimsson
No Relationships to Disclose
 
Herbert Zeh
Research Funding - BBI Healthcare; Bristol Myers Squibb Foundation; Celgene; Five Prime Therapeutics; Forty Seven; Genentech Foundation; GlaxoSmithKline; Incyte; Lilly; Novartis Institutes for BioMedical Research (Inst); Pfizer; Taiho Oncology
Other Relationship - Intuitive Surgical (Inst)
 
Ruth Carlos
Travel, Accommodations, Expenses - GE Healthcare
Other Relationship - Journal of the American College of Radiology. (Inst)
(OPTIONAL) Uncompensated Relationships - GE Healthcare
 
Peter J. O'Dwyer
Consulting or Advisory Role - Array BioPharma; Genentech
Research Funding - Amgen (Inst); Array BioPharma (Inst); BBI Healthcare (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Five Prime Therapeutics (Inst); Forty Seven (Inst); Genentech (Inst); GlaxoSmithKline (Inst); H3 Biomedicine (Inst); Lilly/ImClone (Inst); Minneamrita Therapeutics (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Pharmacyclics (Inst); syndax (Inst); Syndax (Inst); Syndax (Inst); Syndax (Inst); Syndax (Inst); Taiho Pharmaceutical (Inst)
Expert Testimony - Lilly